80 related articles for article (PubMed ID: 27532290)
21. XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro), and GSTP1 (Ile105Val) polymorphisms in prognosis of cutaneous melanoma.
Gomez GV; de Oliveira C; Rinck-Junior JA; de Moraes AM; Lourenço GJ; Lima CS
Tumour Biol; 2016 Mar; 37(3):3163-71. PubMed ID: 26427666
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
[TBL] [Abstract][Full Text] [Related]
23. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
[TBL] [Abstract][Full Text] [Related]
24. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients.
Tan XL; Popanda O; Ambrosone CB; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Chang-Claude J
Breast Cancer Res Treat; 2006 Jun; 97(3):255-62. PubMed ID: 16331344
[TBL] [Abstract][Full Text] [Related]
25. Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study.
He XF; Su J; Zhang Y; Huang X; Liu Y; Ding DP; Wang W; Arparkorn K
Breast Cancer Res Treat; 2011 Nov; 130(2):517-29. PubMed ID: 21604156
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanoma.
Cotignola J; Chou JF; Roy P; Mitra N; Busam K; Halpern AC; Orlow I
J Invest Dermatol; 2012 May; 132(5):1471-8. PubMed ID: 22336942
[TBL] [Abstract][Full Text] [Related]
27. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
[TBL] [Abstract][Full Text] [Related]
28. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
29. Perineural invasion as a major determinant for the aggressiveness associated with increased tumor thickness in t1-2 oral tongue and buccal squamous cell carcinoma.
Tai SK; Li WY; Yang MH; Chu PY; Wang YF; Chang PM
Ann Surg Oncol; 2013 Oct; 20(11):3568-74. PubMed ID: 23838906
[TBL] [Abstract][Full Text] [Related]
30. Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.
Kumari A; Bahl C; Singh N; Behera D; Sharma S
Mol Biol Rep; 2016 Dec; 43(12):1383-1394. PubMed ID: 27614750
[TBL] [Abstract][Full Text] [Related]
31. DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients.
Gal TJ; Huang WY; Chen C; Hayes RB; Schwartz SM
Laryngoscope; 2005 Dec; 115(12):2221-31. PubMed ID: 16369171
[TBL] [Abstract][Full Text] [Related]
32. Influence of Arg72Pro polymorphisms of TP53 on the response of buccal cells to radiotherapy.
Pereira L; Carvalho MR; Fonseca CG; Lima SS; Cerqueira EM; Jorge W; Castro MC
Genet Mol Res; 2011 Dec; 10(4):3552-8. PubMed ID: 22194206
[TBL] [Abstract][Full Text] [Related]
33. Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma.
Lapke N; Lu YJ; Liao CT; Lee LY; Lin CY; Wang HM; Ng SH; Chen SJ; Yen TC
Oncotarget; 2016 Jul; 7(28):44194-44210. PubMed ID: 27283772
[TBL] [Abstract][Full Text] [Related]
34. Role of human papilloma virus in oral tongue squamous cell carcinoma.
Elango KJ; Suresh A; Erode EM; Subhadradevi L; Ravindran HK; Iyer SK; Iyer SK; Kuriakose MA
Asian Pac J Cancer Prev; 2011; 12(4):889-96. PubMed ID: 21790221
[TBL] [Abstract][Full Text] [Related]
35. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India.
Ihsan R; Devi TR; Yadav DS; Mishra AK; Sharma J; Zomawia E; Verma Y; Phukan R; Mahanta J; Kataki AC; Kapur S; Saxena S
DNA Cell Biol; 2011 Mar; 30(3):163-71. PubMed ID: 21043833
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder.
Horikawa Y; Nadaoka J; Saito M; Kumazawa T; Inoue T; Yuasa T; Tsuchiya N; Nishiyama H; Ogawa O; Habuchi T
Oncol Rep; 2008 Jul; 20(1):49-55. PubMed ID: 18575717
[TBL] [Abstract][Full Text] [Related]
37. Association between p53 gene variants and oral cancer susceptibility in population from Gujarat, West India.
Patel KR; Vajaria BN; Begum R; Shah FD; Patel JB; Shukla SN; Patel PS
Asian Pac J Cancer Prev; 2013; 14(2):1093-100. PubMed ID: 23621193
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH
Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
[TBL] [Abstract][Full Text] [Related]
40. Significant association of TP53 Arg72Pro polymorphism in susceptibility to differentiated thyroid cancer.
Khan MS; Pandith AA; Masoodi SR; Khan SH; Rather TA; Andrabi KI; Mudassar S
Cancer Biomark; 2015; 15(4):459-65. PubMed ID: 25835179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
